 |
인쇄하기
취소
|
Two drug makers sanctioned for non-obligation of GMP standards
The Korea Food and Drug Administration says it notified MSD Korea and GSK to have two companies suspend the importation of Cozaar Plus-F tablets and Lamictal tablets, respectively, for one month (from May 14 to April 13) due to local distribution of substandard products.
The administration adds the two companies failed to observe GMP standards, thereby inviting such punitive dispositions.
The administration adds the two companies failed to observe GMP standards, thereby inviting such punitive dispositions.
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.